叶酸补充预防神经管缺陷:美国预防服务工作组更新版证据报告与系统综述
该系统综述纳入24项研究(N>58 860),评估叶酸补充预防神经管缺陷及危害。美国1998年食品强化前的研究显示叶酸补充有保护作用,强化后的病例对照研究未一致显示保护关联,但存在错分和回忆偏倚可能削弱关联。叶酸补充与双胎妊娠、哮喘等危害风险无统计学显著增加。
要点
- 美国1998年食品强化前的研究显示叶酸补充与神经管缺陷风险降低相关。
- 食品强化后的病例对照研究未一致显示叶酸补充的保护关联,OR范围0.93至1.4,置信区间跨越无效值。
- 叶酸补充与双胎妊娠、哮喘、喘息或过敏风险增加无统计学显著关联。
核心结论
- 在美国1998年开始食品强化前开展的研究中,叶酸补充对神经管缺陷具有保护作用。
- 食品强化后较新的研究未显示保护关联,但可能存在错分和回忆偏倚,会削弱所测量的叶酸补充与神经管缺陷的关联。
研究设计与样本
- 系统综述纳入24项研究(N>58 860),检索MEDLINE、Cochrane Library、EMBASE和试验注册库至2016年1月28日,持续监测至2016年11月11日。
- 因异质性,数据未进行合并。
主要发现
- 一项1984年始于匈牙利的随机临床试验中,叶酸补充与微量元素补充相比,神经管缺陷发生率0% vs 0.25%(Peto OR 0.13,95%CI 0.03-0.65;n=4862)。
- 招募于1984至1996年的队列研究OR范围为0.11至0.27(n=19 982)。
- 4项病例对照研究中有3项报告OR范围为0.6至0.7(数据1976至1998年,n>7121)。
- 1998年后数据的病例对照研究未一致显示保护关联,OR范围0.93至1.4,置信区间跨越无效值(n>13 990)。
- 一项试验(OR 1.40,95%CI 0.89-2.21;n=4767)和一项队列研究(OR 1.04,95%CI 0.91-1.18;n=2620)未发现双胎妊娠风险统计学显著增加。
关键数值与推荐
- 三项系统综述未发现哮喘(OR 1.06,95%CI 0.99-1.14;n=14 438)、喘息或过敏风险增加的一致证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 食品强化后较新的研究未显示保护关联,但可能存在错分和回忆偏倚,会削弱所测量的叶酸补充与神经管缺陷的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Neural tube defects are among the most common congenital anomalies in the United States. Periconceptional folic acid supplementation is a primary care-relevant preventive intervention. OBJECTIVE: To review the evidence on folic acid supplementation for preventing neural tube defects to inform the US Preventive Services Task Force for an updated Recommendation Statement. DATA SOURCES: MEDLINE, Cochrane Library, EMBASE, and trial registries through January 28, 2016, with ongoing surveillance through November 11, 2016; references; experts. STUDY SELECTION: English-language studies of folic acid supplementation in women. Excluded were poor-quality studies; studies of prepubertal girls, men, women without the potential for childbearing, and neural tube defect recurrence; and studies conducted in developing countries. DATA EXTRACTION AND SYNTHESIS: Two investigators independently reviewed abstracts, full-text articles, and risk of bias of included studies. One investigator extracted data and a second checked accuracy. Because of heterogeneity, data were not pooled. MAIN OUTCOMES AND MEASURES: Neural tube defects, harms of treatment (twinning, respiratory outcomes). RESULTS: A total of 24 studies (N > 58 860) were included. In 1 randomized clinical trial from Hungary initiated in 1984, incidence of neural tube defects for folic acid supplementation compared with trace element supplementation was 0% vs 0.25% (Peto odds ratio [OR], 0.13 [95% CI, 0.03-0.65]; n = 4862). Odds ratios from cohort studies recruiting participants between 1984 and 1996 demonstrated beneficial associations and ranged from 0.11 to 0.27 (n = 19 982). Three of 4 case-control studies with data from 1976 through 1998 reported ORs ranging from 0.6 to 0.7 (n > 7121). Evidence of benefit led to food fortification in the United States beginning in 1998, after which no new prospective studies have been conducted. More recent case-control studies drawing from data collected after 1998 have not demonstrated a protective association consistently with folic acid supplementation, with ORs ranging from 0.93 to 1.4 and confidence intervals spanning the null (n > 13 990). Regarding harms, 1 trial (OR, 1.40 [95% CI, 0.89-2.21]; n = 4767) and 1 cohort study (OR, 1.04 [95% CI, 0.91-1.18]; n = 2620) found no statistically significant increased risk of twinning. Three systematic reviews found no consistent evidence of increased risk of asthma (OR, 1.06 [95% CI, 0.99-1.14]; n = 14 438), wheezing, or allergy. CONCLUSIONS AND RELEVANCE: In studies conducted before the initiation of food fortification in the United States in 1998, folic acid supplementation provided protection against neural tube defects. Newer postfortification studies have not demonstrated a protective association but have the potential for misclassification and recall bias, which can attenuate the measured association of folic acid supplementation with neural tube defects.
引用
- Viswanathan M, Treiman KA, Kish-Doto J, et al. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017. PMID: 28097361. doi:10.1001/jama.2016.19193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。